<SEC-DOCUMENT>0001193125-25-138461-index.html : 20250610
<SEC-HEADER>0001193125-25-138461.hdr.sgml : 20250610
<ACCEPTANCE-DATETIME>20250610160946
ACCESSION NUMBER:		0001193125-25-138461
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20250610
DATE AS OF CHANGE:		20250610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KAZIA THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-279773
		FILM NUMBER:		251037173

	BUSINESS ADDRESS:	
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVOGEN LTD
		DATE OF NAME CHANGE:	19981228
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d933832d424b3.htm
<DESCRIPTION>424B3
<TEXT>
Document 1 - file: d933832d424b3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g926165dsp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: g926165dsp1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g926165g55d35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g926165g55d35.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g926165g93d71.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g926165g93d71.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g926165g94s53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g926165g94s53.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g933832g0606213249646.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g933832g0606213249646.jpg

</DOCUMENT>
</SEC-DOCUMENT>